Background and Aims: The expression of pancreatic-duodenal homeobox 1 (PDX1)
Introduction
In mammals, epigenetic regulation including DNA hypermethylation and histone modification represents the major epigenetic mechanisms implicated in regulation of gene transcription [1] . DNA methylation within the promoter of tumor suppressor genes is a common phenomenon in cancer cells. It results in the transcriptional silencing of these genes and promotes tumor development [1] [2] [3] [4] . Promoter hypermethylation has been reported to induce aberrant reduction of some homeobox genes such as Aristaless-like homeobox-4 [5] , CDX1 [6] [7] [8] and CDX2 [9] in cancers including squamous esophageal cancer, hematologic malignancies and colorectal cancers.
Histone acetylation/deacetylation alters the status of open chromatin domains and thus affects gene transcription. This process is modulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs). Loss of histone H3 and H4 acetylation attributes to the imbalanced recruitment of HDAC and results in transcription repression of tumor suppressors in cancers [10] . 7 
Western Blot
Whole cell lysates were prepared and assayed for protein expression by western blot as reported previously [24] . Immunoblots were developed and visualized by the enhanced chemiluminescence (ECL) system (Amersham, Piscataway, NJ) according to the manufacturer's protocol. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal loading control.
5'-aza-dC and TSA Treatment
Cancer cells were seeded in 6-well plates at a density of 2 x 10 5 cells per well 12 hours before the drug treatment. The cells were treated with the following drugs alone or in combination: 5'-aza-dC (5, 10 or 20μM, Sigma, St Louis, MO) and TSA (500 nM, Sigma). Cells were harvested after 24 hours. Double diluted water (DDW) was used as the dissolvent control.
Construction of Putative Promoter Fragments
To indentify functional CpG islands and evaluate the association of DNA methylation and promoter transcription, the CpG islands of the PDX1 promoter had to be identified. We searched PDX1 genomic sequence at -2000nt to +600nt using Promoter Database (http://rulai.cshl.edu/cgi-bin/TRED/tred.cgi?process=home) and found four Empty pGL3basic vector was used as control while PRL-CMV (0.008 µg /well, Promega) was used to normalize the reporter gene. 24 hours after transfection, cells were harvested and firefly luciferase activities were measured using the Dual-Luciferase reporter assay system (Promega) with a model TD-20/20
Luminometer (EG&G Berthold, Australia). The value of firefly luciferase activity was normalized to that of renilla luciferase. Promoter activity was presented as the fold change of relative luciferase unit (RLU) compared to the basic vector control. RLU equals the value of the firefly luciferase unit, divided by the value of the renilla. Each experiment was performed in triplicate, and at least 3 sets of independent transfection experiments were performed. SssI methylase, which is capable of non-specifically methylating all CpG dinucleotides, was used for the in vitro methylation of putative promoter fragments. In each case, 3 μg of plasmid DNA (triplicates in 24-well plate), pGL3basic and all reporter constructs were incubated in a 20μl reaction system containing 4 units of SssI methylase, 2μl of 20 x S-adenosylmethionine and 2μl of 10
x NEBuffer for 4 hours at 37℃ followed by 20 minutes at 65℃to stop the reaction.
Genomic DNA Isolation, Bisulfite DNA Sequencing PCR Analysis (BSP) and
Methylation Specific PCR Analysis (MSP)
Genomic DNAs were isolated from cells or resected specimens using DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
DNA samples were treated with sodium bisulfite to convert cytosine to uracil. Briefly, 
Statistical Analysis
The results of luciferase activities are expressed as mean ± SEM. Student t test and
Fisher's Exact Test were used to determine the statistical significance between different groups by the statistical software, SPSS13.0. A p value of less than 0.05 was considered significant.
Results

Restoration of PDX1 expression in cancer cells by demethylation and acetylation
We have reported that PDX1 expression in gastric cancer cells is down-regulated [24].
To examine if epigenetic regulation was involved in PDX1 silencing, we first treated 7
gastric cancer cell lines with 5'-aza-dC. As shown in Figure 1A , the endogenous mRNA expression of PDX1 in gastric cancer cells was weak and partly up-regulated by 5'-aza-dC in these cell lines. Similarly, PDX1 expression could be up-regulated by the HDAC inhibitor, TSA ( Figure 1B ). Furthermore, 5'-aza-dC and TSA could increase PDX1 expression in a dose dependent manner ( Figure 1C ). To evaluate the interaction of 5'-aza-dC and TSA on PDX1 expression, we randomly chose the two cell lines TMK1 and KATOIII. As shown in Figure 1D and E, a slightly synergistic effect was observed when cells were treated with combination of 5'-aza-dC and TSA.
These results suggested that PDX1 expression in gastric cancer cells was modulated by epigenetic regulation that included both DNA methylation and histone deacetylation.
Hypermethylation of PDX1 promoter in gastric cancer cell lines
To define the putative responsive sequence for epigenetic regulation, we first searched a 2600bp genomic sequence including the ATG translation starting codon (-2000nt to +600nt) of the PDX1 gene using Methprimer software (http://www.ucsf.edu/urogene /methprimer). Four putative CpG islands were found located at -1975nt to -1704nt, -1226nt to -1066nt, -818nt to -694nt and -112nt to +521nt, respectively ( Figure 2A ).
We then examined the methylation status of these CpG islands in 7 gastric cancer cell lines by MSP assay. Complete methylation in all four CpG islands was found in SGC7901, AGS, TMK1 and SNU1 cells while partial methylation was found in all
CpG islands except F383 in BCG823 and MKN45 cells. However, we showed no DNA methylation of all four islands examined in KATOIII cells as well as in normal gastric tissue ( Figure 2B ). To confirm the accuracy of the MSP methodology, we treated TMK1 cells with 5'-aza-dC. We found that the complete methylation in all four CpG islands was successfully reversed into partial methylation ( Figure 2C ).
These results suggested that hypermethylation of PDX1 promoter existed in most of gastric cancer cell lines. 
Identification of a functional
Hypermethylaiton of CpG dinucleotides within F383 fragment
Next, we analyzed the methylation status of CpG dinucleotides within the F383 fragment using BSP analysis. As shown in figure 4A (wildtype sequence), 17 CpG sites were presented in this fragment. All of them were candidate sites for methylation since none of them was altered into T after bisulfite modification ( Figure 1A , modified sequence). Again no methylation was found in all 17 CpG sites in KATOIII cells, and all other cell lines displayed high levels of methylation in the 17 CpG sites.
As low as 1.96% ± 1.24% and 0.98% ± 0.97% of methylation were found in the two normal tissues (p<0.0001 compared to cancer cell lines, Figure 4B and C 
Aberrant hypermethylation of F383 in gastric cancerous tissues
To 
Role of histone acetylation in PDX1 transcription
To characterize the role of acetylation in PDX1 silencing, we detected the association between PDX1 promoter and acetylated histones using ChIP assay followed by q-RT-PCR. We showed that F314, F283 and F724 fragments, which had no obvious promoter activity ( Figure 3A) , could all bind to acetylated histone H3 and H4,most notably in TMK1 cells ( Figure 6A ). However, the association between these fragments and acetylated histones in KATOIII cells were at low levels ( Figure 6A ).
This finding indicated the presence of hypoacetylation in KATOIII cells but not in TMK1 cells in these promoter areas. Regarding F383, its association with acetylated histone H3 or H4 were absent or only at low levels in both cell lines ( Figure 6A ), suggesting F383 is a common fragment for deacetylated regulation in both cell lines.
To further confirm this finding, we examined the association between acetylated histones and F383 in cells treated with TSA. We found that the level of histone H3
and histone H4 associated with F383 was significantly increased by TSA. The fold change of acetylated H3 and H4 were 249.60 ± 17.27 and 1.84 ± 0.09 in TMK1 cells and 3.92 ± 0.11 and 4.06 ± 0.11 in KATOIII cells (p<0.05, Figure 6B ). Finally, we treated the reporter constructs of F383 with TSA in vitro. We showed that TSA upregulated the transcription activity of F383 to as high as 8.70 ± 0.04 folds in KATOIII cells (p<0.001, Figure 6C ). These findings suggest that this fragment is an important responsive sequence for histone deacetylation. 
